Mar. 18, 2019 |
|
June. 14, 2024 |
|
jRCTs032180340 |
Performance Evaluation of cardioREPO in stress myocardial perfusion scintigraphy for patients with ischemic heart disease |
|
cardioREPO study |
Miyauchi Hideyuki |
||
Chiba University Hospital |
||
1-8-1, Inohana, Chuo-ku, Chiba, JAPAN |
||
+81-43-222-7171 |
||
hmiyauchi@chiba-u.jp |
||
Miyauchi Hideyuki |
||
Chiba University Hospital |
||
1-8-1, Inohana, Chuo-ku, Chiba, JAPAN |
||
+81-43-222-7171 |
||
hmiyauchi@chiba-u.jp |
Recruiting |
Nov. 16, 2018 |
||
Feb. 14, 2019 | ||
180 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
no treatment control/standard of care control |
||
single assignment |
||
diagnostic purpose |
||
1) Patients undergoing stress myocardial perfusion SPECT |
||
1) Patients who are contraindication to stress myocardial perfusion SPECT |
||
20age old over | ||
No limit | ||
Both |
||
Ishcemic heart disease |
||
Using personal medical data of patients |
||
To evaluate the diagnostic accuracy of cardioREPO in coronary artery branch area (left anterior descending, left circumflex, right coronary artery), using image analysis of the myocardial perfusion scintigraphy for patients with ischemic heart disease. |
||
PDRadiopharma Inc. (The name of the company at the time of funding was FUJIFILM RI Pharma Co., Ltd.) | |
Not applicable |
Chiba University Certified Clinical Research Review Board | |
1-8-1 Inohana chou-ku Chiba, Japan, Chiba | |
+81-43-226-2616 |
|
prc-jim@chiba-u.jp | |
Approval | |
Mar. 04, 2019 |
No |
|
UMIN000022294 | |
UMIN |
none |